- EDT device (Photo: Business Wire)
- 2024년 9월 4일 14:35
- Rigaku Holdings Corporation
- Electron density of a monoclonal antibody revealed by EDT (Photo: Business Wire)
- 2024년 9월 4일 14:35
- Rigaku Holdings Corporation
- The structural model of amorphous carbon (left), estimated by TXS-RMC using SmartLab (right) (Graphic: Business Wire)
- 2024년 11월 15일 16:00
- Rigaku Holdings Corporation
- Ribbon Cutting of the Lab (Photo: Business Wire)
- 2024년 11월 22일 16:40
- Rigaku Holdings Corporation
- XSPA-200 ER mounted on a MiniFlex (Photo: Business Wire)
- 2024년 12월 6일 17:15
- Rigaku Holdings Corporation
- XSPA-200 ER (Photo: Business Wire)
- 2024년 12월 6일 17:15
- Rigaku Holdings Corporation
- Kiyoshi Ogata, Senior Executive Vice President, Rigaku Holdings Corporation (Photo: Business Wire)
- 2024년 12월 18일 17:15
- Rigaku Holdings Corporation
- Avishai Shklar, Chief Executive Officer (CEO) of RSI (Photo: Business Wire)
- 2024년 12월 18일 17:15
- Rigaku Holdings Corporation
- 200nm-scale hole pattern in silicon, inspected and measured using this technology (Graphic: Business Wire)
- 3월 12일 11:05
- Rigaku Holdings Corporation
- The Award (Photo: Business Wire)
- 3월 12일 11:05
- Rigaku Holdings Corporation
- Left: Keitaro Iwaki, President & Representative Director, SPERA PHARMA; Right: Jun Kawakami, President & CEO, Rigaku
- 4월 20일 11:45
- Rigaku Holdings Corporation